top of page
Executive Spotlights

Pfizer snaps up Seagen for $43 bln as Drugmaker extends buying spree

New York, NY, March 13, 2023 (Reuters) -- Pfizer Inc struck a $43 billion deal to buy Seagen Inc in the U.S. drugmaker's biggest in a string of acquisitions undertaken after a sales windfall from its COVID-19 products.

Read full article here.

Recent Posts

See All

Rahway, NJ & Cambridge, MA, November 21, 2023 (Business Wire) -- Merck (NYSE: MRK), also known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. declare a definitive agr

Life Science Headlines
bottom of page